PENTIXAPHARM
PentixaPharm GmbH, a joint venture of Scintomics GmbH and 1717 Life Science Ventures GmbH, is committed to develop PentixaFor and PentixaTher as a theranostic radiopharmaceutical pair, specifically targeting the CXCR4-receptor expressed in most fast progressing diseases, particularly malignant cancers. Funding is dedicated for a phase II trial of the imaging compound PentixaFor and for a phase I trial of the therapeutic compound PentixaTher in Central Nervous System (CNS) Lymphoma while supporting proof-of-concept studies in various other indications.
PENTIXAPHARM
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2019-01-01
Address:
Würzburg, Bayern, Germany
Country:
Germany
Website Url:
http://www.pentixapharm.com
Total Employee:
1+
Status:
Active
Total Funding:
15 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network JsDelivr Dynatrace
Similar Organizations
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Current Employees Featured
Founder
Investors List
Eckert Life Science Accelerator
Eckert Life Science Accelerator investment in Series A - Pentixapharm
Official Site Inspections
http://www.pentixapharm.com Semrush global rank: 5.2 M Semrush visits lastest month: 1.56 K
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
